Novartis aims to bottle more than 50 million doses of BioNTech’s COVID-19 vaccine this year at its fill-and-finish facility in Stein, Switzerland, as reported in KFGO.

The news comes after the European Union’s drug regulator approved the bottling plant.










(All Rights Reserved)